Answers are grounded in this paper and cite their sources.
Periurethral injection of bulking agents is a technique used to treat urinary incontinence due to stress incontinence, preferably caused by intrinsic sphincter deficiency. The variety of the nature of existing bulking agents leads to different success rates and complications. This case report describes the formation of pseudo-abcesses after periurethral injections with a bioresorbable implant consisting of synthetic polycaprolactone microspheres suspended in a carboxymethylcellulose gel carrier.
No takes yet. Share an insight, caveat, or question.
Budo et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: